BioNTech and Pfizer File mRNA Vaccine Patent Countersuit Against Moderna

As the salad days of pandemic vaccine sales wane, two mRNA camps are taking a legal stand on the global stage—and duking it out in the name of drug delivery.

In response to an August lawsuit from Moderna alleging patent infringement related to its COVID-19 vaccine technology, Pfizer and BioNTech have hit back with a countersuit, demanding a jury trial and refuting Moderna’s claims of infringement.

In Moderna’s original suit, the company accused Pfizer and BioNTech of stepping on Moderna’s patents filed between 2010 and 2016 and sought to “protect” its innovative mRNA technology that it “pioneered, invested billions of dollars into creating, and patented” during the decade proceeding the pandemic, CEO Stéphane Bancel said in a statement at the time.

Read the source article at fiercepharma.com